AnaCardio AB, a pioneering clinical stage biopharmaceutical company hailing from Sweden, is excited to announce the successful raise of $19 million in a recent funding round. This substantial investment will enable AnaCardio to further its mission of developing innovative therapies aimed at treating heart failure, a condition that significantly impacts millions worldwide. Based on groundbreaking research from the esteemed Karolinska Institutet, AnaCardio is at the forefront of heart health innovation, working on its lead program, AC01. This program is set to enter phase 2 clinical development in heart failure patients in 2022, representing a critical step towards advancing treatments that enhance heart muscle contractility through a unique and differentiated mechanism. As heart disease remains one of the leading causes of mortality globally, the funding will be instrumental in propelling the clinical trials and supporting the development of AC01, potentially transforming the landscape of heart failure management. In a landscape dominated by conventional approaches, AnaCardio’s commitment to innovation positions the company as a trailblazer, and this funding marks a vital milestone in its journey to deliver improved health outcomes for patients suffering from heart failure. For more information on AnaCardio’s pioneering work, please visit www.anacardio.com.
AnaCardio Secures $19 Million in Series A Funding for Innovative Heart Failure Treatments
Recently funded · $19.0M Series aBiopharmaceutical
Get the full AnaCardio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
